Juan Martin-Liberal

7PUBLICATIONS
111CO-AUTHORS
Molecular targetsSolid tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2024
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.

Juan Martin-Liberal, Elena Garralda, Jesús García-Donas

|Mar 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.

Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno

|Aug 31, 2023
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).

Alexandra Drakaki, Thomas Powles, Aristotelis Bamias

|Feb 07, 2023
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.

Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero

|Oct 06, 2022
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.

Aleix Prat, Luis Paz-Ares, Manel Juan

Pageof 2